The "INSIGHT" trial: An explorative, open-labeled phase I study to evaluate the feasibility and safety of intra-tumoral, intra-peritoneal, and subcutaneous injections with IMP321 (LAG-3Ig fusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback